La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Cencora Gestione

Gestione criteri di controllo 3/4

Cencora's Il CEO è Steve Collis, nominato in Nov2010, e ha un mandato di 13.75 anni. la retribuzione annua totale è $ 17.51M, composta da 8% di stipendio e 92% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.15% delle azioni della società, per un valore di R$ 367.48M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.6 anni e 9.3 anni.

Informazioni chiave

Steve Collis

Amministratore delegato

US$17.5m

Compenso totale

Percentuale dello stipendio del CEO	8.0%
Mandato del CEO	13.8yrs
Proprietà del CEO	0.1%
Durata media del management	5.8yrs
Durata media del Consiglio di amministrazione	9.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Steve Collis rispetto agli utili di Cencora?
Data	Compenso totale	Stipendio	Guadagni aziendali
Jun 30 2024	n/a	n/a	US$2b
Mar 31 2024	n/a	n/a	US$2b
Dec 31 2023	n/a	n/a	US$2b
Sep 30 2023	US$18m	US$1m	US$2b
Jun 30 2023	n/a	n/a	US$2b
Mar 31 2023	n/a	n/a	US$2b
Dec 31 2022	n/a	n/a	US$2b
Sep 30 2022	US$17m	US$1m	US$2b
Jun 30 2022	n/a	n/a	US$2b
Mar 31 2022	n/a	n/a	US$2b
Dec 31 2021	n/a	n/a	US$2b
Sep 30 2021	US$15m	US$1m	US$2b
Jun 30 2021	n/a	n/a	-US$4b
Mar 31 2021	n/a	n/a	-US$4b
Dec 31 2020	n/a	n/a	-US$3b
Sep 30 2020	US$14m	US$1m	-US$3b
Jun 30 2020	n/a	n/a	US$2b
Mar 31 2020	n/a	n/a	US$2b
Dec 31 2019	n/a	n/a	US$649m
Sep 30 2019	US$11m	US$1m	US$855m
Jun 30 2019	n/a	n/a	US$956m
Mar 31 2019	n/a	n/a	US$930m
Dec 31 2018	n/a	n/a	US$1b
Sep 30 2018	US$12m	US$1m	US$2b
Jun 30 2018	n/a	n/a	US$1b
Mar 31 2018	n/a	n/a	US$855m
Dec 31 2017	n/a	n/a	US$979m
Sep 30 2017	US$10m	US$1m	US$364m

Compensazione vs Mercato: La retribuzione totale di Steve ($USD 17.51M ) è superiore alla media delle aziende di dimensioni simili nel mercato BR ($USD 6.10M ).

Compensazione vs guadagni: La retribuzione di Steve è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Steve Collis (63 yo)

13.8yrs

Mandato

US$17,511,240

Compensazione

Mr. Steven H. Collis, also known as Steve, has been the Chief Executive Officer and President of Cencora, Inc. (formerly known as AmerisourceBergen Corporation) since July 2011 and November 2010 respective...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Steven Collis	Chairman	13.8yrs	US$17.51m	0.15% $ 347.5m
James Cleary	Executive VP & CFO	5.8yrs	US$5.45m	0.058% $ 139.0m
Robert Mauch	Executive VP & COO	1.9yrs	US$7.70m	0.012% $ 29.7m
Gina Clark	Executive VP and Chief Communications & Administration Officer	7.3yrs	US$3.17m	0.0068% $ 16.2m
Elizabeth Campbell	Executive VP & Chief Legal Officer	3yrs	US$4.03m	0.0042% $ 10.1m
Lazarus Krikorian	Senior VP	12.7yrs	Nessun dato	0.010% $ 24.4m
Bennett Murphy	Senior Vice President of Investor Relations	no data	Nessun dato	Nessun dato
Jennifer Dubas	Senior VP & Chief Compliance Officer	no data	Nessun dato	Nessun dato
Silvana Battaglia	Executive VP & Chief Human Resources Officer	5.7yrs	US$3.48m	0.0056% $ 13.4m
Ann Anaya	Senior VP and Chief Diversity Equity & Inclusion Officer	2.7yrs	Nessun dato	Nessun dato
J. Quinn	VP & Corporate Treasurer	no data	Nessun dato	Nessun dato
Brian Nightengale	President of Good Neighbor Pharmacy	8.1yrs	Nessun dato	Nessun dato

5.8yrs

Durata media

59yo

Età media

Gestione esperta: Il team dirigenziale di C1CO34 è esperto e expertise (durata media dell'incarico 5.6 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Steven Collis	Chairman	13.3yrs	US$17.51m	0.15% $ 347.5m
Lauren Tyler	Independent Director	less than a year	Nessun dato	Nessun dato
Richard Gochnauer	Independent Director	16yrs	US$300.10k	0.011% $ 27.4m
Mark M. Durcan	Lead Independent Director	9yrs	US$380.05k	0.010% $ 23.9m
Lon Greenberg	Independent Director	11.3yrs	US$332.60k	0.0057% $ 13.7m
Kathleen Hyle	Independent Director	14.3yrs	US$320.10k	0.011% $ 25.6m
Dennis Nally	Independent Director	4.7yrs	US$375.36k	0.0044% $ 10.6m
Ornella Barra	Director	9.7yrs	Nessun dato	Nessun dato
Henry McGee	Independent Director	19.8yrs	US$320.10k	0.0077% $ 18.3m
Werner Baumann	Independent Director	less than a year	Nessun dato	Nessun dato
Lorence Kim	Independent director	1.9yrs	US$397.33k	0.000090% $ 215.0k
Redonda Miller	Independent Director	1.7yrs	US$311.82k	0.00080% $ 1.9m

9.3yrs

Durata media

64yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di C1CO34 sono considerati esperti (durata media dell'incarico 9.3 anni).

Cencora Gestione

Gestione criteri di controllo 3/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Cencora, Inc. Elects Frank Clyburn as New Independent Director, Effective October 1, 2024

Cencora, Inc. Announces CEO Changes, Effective October 1, 2024

Cencora, Inc., Annual General Meeting, Mar 12, 2024

Cencora, Inc., Annual General Meeting, Mar 12, 2024

Amerisourcebergen Corporation Elects Werner Baumann and Lauren Tyler to Its Board of Directors

AmerisourceBergen Corporation, Annual General Meeting, Mar 09, 2023

Recent updates

Cencora, Inc. Elects Frank Clyburn as New Independent Director, Effective October 1, 2024

Cencora, Inc. Declares Quarterly Cash Dividend, Payable on August 26, 2024

Cencora, Inc. to Report Q3, 2024 Results on Jul 31, 2024

Cencora, Inc. Declares Quarterly Cash Dividend on Common Share, Payable on May 24, 2024

Cencora, Inc. (NYSE:COR) announces an Equity Buyback for $2,000 million worth of its shares.

Cencora, Inc. to Report Q2, 2024 Results on May 01, 2024

Cencora, Inc. Reaffirms Guidance for Year 2024

Cencora, Inc. Announces CEO Changes, Effective October 1, 2024

Cencora’s FormularyDecisions Launches Payer Resource for Cell and Gene Therapy Products

Cencora, Inc. Declares Quarterly Cash Dividend on Common Share, Payable on February 26, 2024

Cencora, Inc., Annual General Meeting, Mar 12, 2024

Cencora, Inc., Annual General Meeting, Mar 12, 2024

Cencora, Inc. to Report Q1, 2024 Results on Jan 31, 2024

Cencora, Inc. Declares Quarterly Dividend, Payable November 27, 2023

Cencora, Inc. to Report Q4, 2023 Results on Nov 02, 2023

Amerisourcebergen Corporation Elects Werner Baumann and Lauren Tyler to Its Board of Directors

AmerisourceBergen Corporation Declares Quarterly Cash Dividend, Payable on August 28, 2023

AmerisourceBergen Corporation to Report Q3, 2023 Results on Aug 02, 2023

TPG Inc. (NasdaqGS:TPG), AmerisourceBergen Corporation (NYSE:ABC) and the management team of OneOncology, Inc. acquired OneOncology, LLC from General Atlantic Service Company, L.P. and others.

An unknown buyer acquired Brazil specialty business from AmerisourceBergen Corporation (NYSE:ABC).

AmerisourceBergen Corporation, Annual General Meeting, Mar 09, 2023

AmerisourceBergen Corporation, Annual General Meeting, Mar 09, 2023

AmerisourceBergen Corporation to Report Q1, 2023 Results on Feb 01, 2023

AmerisourceBergen Corporation Elects Redonda Miller to Its Board of Directors, Effective January 1, 2023

AmerisourceBergen Corporation has completed a Follow-on Equity Offering in the amount of $1.546 billion.

AmerisourceBergen Corporation Appoints Robert P. Mauch as Executive Vice President and Chief Operating Officer

AmerisourceBergen Corporation to Report Q4, 2022 Results on Nov 03, 2022

AmerisourceBergen Elects Lorence H. Kim, M.D., to Its Board of Directors

AmerisourceBergen Corporation (NYSE:ABC) agreed to acquire Pharmalex Holding Gmbh from AUCTUS Capital Partners AG for €1.3 billion.

AmerisourceBergen Corporation (NYSE:ABC) agreed to acquire Pharmalex Holding Gmbh for €1.28 billion.

AmerisourceBergen Corporation Reports Goodwill Impairment for the Three Months Ended June 30, 2022

AmerisourceBergen to Launch Digital Therapeutics Platform to Facilitate Access to Innovative Products

AmerisourceBergen Corporation to Report Q3, 2022 Results on Aug 03, 2022

AmerisourceBergen Corporation (NYSE:ABC) announces an Equity Buyback for $1,000 million worth of its shares.

AmerisourceBergen Launches Clinical Trial Navigator to Bolster Equitable and Accessible Community-Based Research Opportunities Nationwide

An unknown buyer acquired 2.9% stake in AmerisourceBergen Corporation (NYSE:ABC) from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for $900 million.

Amerisourcebergen Corporation Corporation Declares Quarterly Cash Dividend, Payable on May 31, 2022

AmerisourceBergen Launches $150 Million Venture Capital Fund

AmerisourceBergen Corporation to Report Q2, 2022 Results on May 04, 2022

AmerisourceBergen, Cardinal Health and McKesson Approve Opioid Settlement Agreement

AmerisourceBergen Corporation Declares a Quarterly Cash Dividend, Payable on February 28, 2022

AmerisourceBergen Corporation, Annual General Meeting, Mar 10, 2022

AmerisourceBergen Corporation, Annual General Meeting, Mar 10, 2022

AmerisourceBergen and TrakCel Launch Integrated Platform to Support Cell and Gene Therapies

AmerisourceBergen Corporation Debuts RFID Tagging Service, Allowing Customers Nationwide to Purchase Pre-Tagged Product That Is Also Technology Agnostic

AmerisourceBergen, Cardinal Health and McKesson Announce Settlement with Cherokee Nation

AmerisourceBergen Corporation(NYSE:ABC) dropped from Russell Midcap Growth Index

AmerisourceBergen Corporation Provides Earnings Guidance for the Fiscal Year 2021

AmerisourceBergen Corporation Declares a Quarterly Cash Dividend, Payable on June 1, 2021

Amerisourcebergen Corporation Updates Earnings Guidance for the Fiscal 2021

AmerisourceBergen Corporation, Annual General Meeting, Mar 11, 2021

AmerisourceBergen Corporation to Report Q1, 2021 Results on Feb 04, 2021

AmerisourceBergen Appoints Lonie Haynes as New SVP and Chief Diversity & Inclusion Officer

Exeter Property Group, LLC acquired PharMEDium property from AmerisourceBergen Corporation (NYSE:ABC) for $5 million.

AmerisourceBergen Corporation to Report Q4, 2020 Results on Nov 05, 2020

AmerisourceBergen Corporation to Report Q2, 2019 Results on May 02, 2019

Analisi delle retribuzioni degli amministratori delegati

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media